ESMOCARD

This brand name is authorized in Estonia, France, Croatia, Ireland, Lithuania, Poland, South Africa

Active ingredients

The drug ESMOCARD contains one active pharmaceutical ingredient (API):

1 Esmolol UNII V05260LC8D - ESMOLOL HYDROCHLORIDE

Esmolol is a beta-selective (cardioselective) receptor blocking agent. At therapeutic doses esmolol has no significant intrinsic sympathicomimetic activity (ISA) or membrane stabilising activity. Read about Esmolol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C07AB09	Esmolol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1253089, 1436824, 1491285
Country: FR	Base de données publique des médicaments	Identifier(s): 65388426, 65650469
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-243481564
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1023314, 1050542
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100197583, 100197590, 100243290
Country: ZA	Health Products Regulatory Authority	Identifier(s): 45/5.2/0806